title: Myasthenia gravis: helping patients have better outcomes.
abstract: Myasthenia gravis (MG) is the most common primary disorder of neuromuscular transmission. MG can be treated as a chronic disease with medication, surgery, plasmapheresis, and I.V. immunoglobulin.
authors: Department of Nursing at Kingsborough Community College, Brooklyn, NY, USA.
authors: Bridget H
authors: BH
authors: Weeks
mesh_terms: D002908:Chronic Disease; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000628:therapy*; D010956:Plasmapheresis; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous